| scholarly article | Q13442814 |
| P50 | author | Oliver Smithies | Q216318 |
| P2093 | author name string | C Nataraj | |
| P J Mannon | |||
| P Ruiz | |||
| T M Coffman | |||
| R B Mannon | |||
| L P Audoly | |||
| C S Amuchastegui | |||
| M I Oliverio | |||
| P2860 | cites work | A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase | Q24296311 |
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Transcription factors of the NFAT family: regulation and function | Q28237645 | ||
| A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 | ||
| Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor | Q28301248 | ||
| Isolation of the cyclosporin-sensitive T cell transcription factor NFATp | Q28511815 | ||
| Signal transduction by lymphocyte antigen receptors | Q29619894 | ||
| Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation | Q29620223 | ||
| The mechanism of action of cyclosporin A and FK506 | Q30014847 | ||
| Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells | Q30460026 | ||
| Leukocytes synthesize angiotensinogen | Q30464630 | ||
| Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. | Q30789537 | ||
| Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas | Q33990760 | ||
| Regulation of blood pressure by the type 1A angiotensin II receptor gene | Q34451124 | ||
| Identification of a human neutrophil angiotension II-generating protease as cathepsin G | Q37013666 | ||
| Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts | Q37382898 | ||
| Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1 | Q40184057 | ||
| Angiotensin II receptors and angiotensin II receptor antagonists. | Q40846126 | ||
| Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice | Q40849726 | ||
| Angiotensin II signal transduction and the mitogen-activated protein kinase pathway | Q40954037 | ||
| Angiotensin receptors and their therapeutic implications | Q41048160 | ||
| Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease | Q41149483 | ||
| Differential expression of angiotensin receptor 1A and 1B in mouse | Q41449603 | ||
| Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes | Q41573426 | ||
| Angiotensin II and gene expression in the kidney | Q41681055 | ||
| New insights into the cellular signaling of seven transmembrane receptors: the role of tyrosine phosphorylation. | Q41699873 | ||
| Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells | Q41717318 | ||
| Monocyte heterogeneity in angiotensin-converting enzyme induction mediated by autologous T lymphocytes | Q42451022 | ||
| Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506. | Q44051970 | ||
| JAK/STAT signaling by cytokine receptors | Q46606420 | ||
| Angiotensin II increases monocyte binding to endothelial cells | Q47629316 | ||
| Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. | Q52219942 | ||
| Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition | Q57396540 | ||
| Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism | Q57703972 | ||
| Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from alpha-factor arrest in yeast | Q59064521 | ||
| Characterization of angiotensin II receptor subtypes in the rat spleen | Q67504995 | ||
| Comparison of the T lymphocyte-dependent induction of angiotensin-converting enzyme and leucine aminopeptidase in cultured human monocytes | Q67914235 | ||
| Synthesis, transfer, and phosphorylation of phosphoinositides in cardiac membranes | Q68490062 | ||
| Evidence for the presence of angiotensins in normal, unstimulated alveolar macrophages and monocytes | Q69589509 | ||
| Functional angiotensin II receptors on macrophages from isolated liver granulomas of murine Schistosoma mansoni | Q70202264 | ||
| Chemotactic response of splenic mononuclear cells to angiotensin II in murine schistosomiasis | Q70302634 | ||
| Granuloma macrophages in murine schistosomiasis mansoni generate components of the angiotensin system | Q70387595 | ||
| Characterization of glomerular thromboxane receptors in murine lupus nephritis | Q70569535 | ||
| Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril | Q70866680 | ||
| Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis | Q71656403 | ||
| Effect of angiotensin II on macrophage functions | Q71665328 | ||
| Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function | Q71907850 | ||
| A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes | Q72097683 | ||
| Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors | Q72265454 | ||
| Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines | Q72357967 | ||
| An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis | Q72711509 | ||
| Cells originating from sarcoid granulomas in vitro | Q72913810 | ||
| Mouse angiotensin receptor genes Agtr1a and Agtr1b map to chromosomes 13 and 3 | Q73208083 | ||
| Cytosolic calcium changes induced by angiotensin II in human peripheral blood mononuclear cells are mediated via angiotensin II subtype 1 receptors | Q73656079 | ||
| Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats | Q74284346 | ||
| The effect of angiotensin II on human mononuclear cell reactivity: suppression of PHA-P-induced thymidine incorporation | Q93660135 | ||
| Angiotensin II inhibition of mitogen- and antigen-induced human blood mononuclear cell thymidine uptake | Q93673822 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1693-1701 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | |
| P478 | volume | 104 |
| Q41784759 | A new cardiac MASTer switch for the renin-angiotensin system |
| Q36085541 | A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. |
| Q36911946 | A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension |
| Q46653976 | AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury |
| Q34817746 | Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis |
| Q25257361 | Alterations of renal phenotype and gene expression profiles due to protein overload in NOD-related mouse strains |
| Q43004586 | Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice |
| Q74509519 | An essential role of angiotensin II receptor type 1a in recipient kidney, not in transplanted peripheral blood leukocytes, in progressive immune-mediated renal injury |
| Q35215135 | Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney |
| Q26991828 | Angiotensin II in inflammation, immunity and rheumatoid arthritis |
| Q53078517 | Angiotensin II increases sperm phagocytosis by neutrophils in vitro: A possible physiological role in the bovine oviduct. |
| Q33829848 | Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells |
| Q37366984 | Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8(+) T cells |
| Q42182054 | Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q31935145 | Angiotensin, inflammation, hypertension, and cardiovascular disease. |
| Q38852480 | Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus |
| Q38112273 | Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis |
| Q37315775 | Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway |
| Q46041669 | Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families |
| Q47581805 | Association study of ACE polymorphisms and systemic lupus erythematosus in Northern Chinese Han population |
| Q38107039 | Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to sarcoidosis: A meta-analysis |
| Q58797436 | Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study |
| Q34315544 | Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling |
| Q57787457 | Blocking of Type 1 Angiotensin II Receptor Inhibits T-lymphocyte Activation and IL-2 Production |
| Q73684222 | Can ACE inhibitors prevent chronic allograft failure? |
| Q54662635 | Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. |
| Q34507683 | Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach |
| Q34065655 | Classical Renin-Angiotensin system in kidney physiology |
| Q90734448 | Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts |
| Q37803475 | Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system |
| Q91720602 | Could angiotensin-modulating drugs be relevant for the treatment of Trypanosoma cruzi infection? A systematic review of preclinical and clinical evidence |
| Q44014644 | Cyclosporin A inhibits angiotensin II-induced c-Jun NH(2)-terminal kinase activation but not protein synthesis in vascular smooth muscle cells |
| Q34454645 | DC isoketal-modified proteins activate T cells and promote hypertension. |
| Q26752811 | Dendritic Cells and Their Role in Cardiovascular Diseases: A View on Human Studies |
| Q39041864 | Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension |
| Q81306325 | Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells |
| Q108443213 | Development of ACE2 autoantibodies after SARS-CoV-2 infection |
| Q46963748 | Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities”. |
| Q39737596 | Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis |
| Q34993934 | Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies |
| Q73398071 | Glomerular hypertension--an under-appreciated aspect of chronic rejection |
| Q37143338 | Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis |
| Q37243199 | Immune and inflammatory role in renal disease. |
| Q26829076 | Immune dysfunction in uremia—an update |
| Q39115238 | Immunologic Effects of the Renin-Angiotensin System |
| Q35747734 | Immunosuppressive treatment protects against angiotensin II-induced renal damage |
| Q35099157 | Inflammation and angiotensin II. |
| Q57021528 | Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure |
| Q36170046 | Inhibitory effects of telmisartan on culture and proliferation of and Kv1.3 potassium channel expression in peripheral blood CD4+ T lymphocytes from Xinjiang Kazakh patients with hypertension |
| Q33987660 | Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting |
| Q42419570 | Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension |
| Q34612453 | Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response |
| Q37307983 | Is hypertension an immunologic disease? |
| Q34315999 | Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs |
| Q35576468 | Lymphocyte responses exacerbate angiotensin II-dependent hypertension |
| Q47368141 | Macrophages under pressure: the role of macrophage polarization in hypertension. |
| Q46289718 | Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury |
| Q34381424 | Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease. |
| Q26771362 | New Concepts in Malaria Pathogenesis: The Role of the Renin-Angiotensin System |
| Q90682463 | New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension |
| Q37809435 | New insights into angiotensin receptor actions: from blood pressure to aging |
| Q55712496 | Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling. |
| Q35911536 | ONZIN deficiency attenuates contact hypersensitivity responses in mice |
| Q43227023 | PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways |
| Q44608583 | Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor |
| Q83194646 | Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction |
| Q36257966 | Protective effects of angiotensin II interruption: evidence for antiinflammatory actions |
| Q35262970 | Psoriasis and high blood pressure |
| Q33867611 | Psoriasis and hypertension severity: results from a case-control study |
| Q37743164 | Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions |
| Q34260674 | Recent advances involving the renin-angiotensin system |
| Q28361862 | Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse |
| Q37100479 | Regulation of T-cell function by endogenously produced angiotensin II. |
| Q44838071 | Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory |
| Q46100560 | Renin-angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis |
| Q55517008 | Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. |
| Q39778121 | Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth |
| Q36229028 | Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction |
| Q30424339 | Role of the immune system in hypertension: modulation by dietary antioxidants |
| Q34013918 | Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension |
| Q47706847 | Salt, Hypertension, and Immunity. |
| Q46735579 | Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury |
| Q50861734 | Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension. |
| Q36844520 | Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension |
| Q28364369 | Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors |
| Q38945115 | T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation. |
| Q97543051 | TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2 |
| Q37643882 | Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria |
| Q74114788 | The complex genetics of scleroderma |
| Q37433886 | The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension |
| Q47818128 | The effects of telmisartan on the nuclear factor of activated T lymphocytes signalling pathway in hypertensive patients |
| Q35038155 | The immune system and hypertension. |
| Q37524979 | The renin-angiotensin system: an old, newly discovered player in immunoregulation |
| Q39157390 | The role of macrophages in hypertension and its complications |
| Q36532932 | The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases |
| Q38996970 | Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis. |
| Q37953776 | Under pressure: the search for the essential mechanisms of hypertension |
| Q38114223 | β-Arrestins in the immune system |
Search more.